| Cardiac dysfunction and thrombocytopenia-associated multiple organ failure inflammation phenotype in a severe paediatric case of COVID-19 G Latimer, C Corriveau, RL DeBiasi, B Jantausch, M Delaney, C Jacquot, ... The Lancet Child & Adolescent Health 4 (7), 552-554, 2020 | 67 | 2020 |
| Mechanistic investigations of human reticulocyte 15-and platelet 12-lipoxygenases with arachidonic acid AT Wecksler, C Jacquot, WA Van Der Donk, TR Holman Biochemistry 48 (26), 6259-6267, 2009 | 59 | 2009 |
| Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low‐resource settings AD Ware, C Jacquot, AAR Tobian, EA Gehrie, PM Ness, EM Bloch Vox sanguinis 113 (1), 3-12, 2018 | 46 | 2018 |
| Isotope sensitive branching and kinetic isotope effects in the reaction of deuterated arachidonic acids with human 12-and 15-lipoxygenases C Jacquot, AT Wecksler, CM McGinley, EN Segraves, TR Holman, ... Biochemistry 47 (27), 7295-7303, 2008 | 41 | 2008 |
| Kinetics of viral clearance and antibody production across age groups in children with severe acute respiratory syndrome coronavirus 2 infection B Bahar, C Jacquot, YD Mo, RL DeBiasi, J Campos, M Delaney The Journal of Pediatrics 227, 31-37. e1, 2020 | 30 | 2020 |
| Soft-tissue aneurysmal bone cyst with translocation t (17; 17)(p13; q21) corresponding to COL1A1 and USP6 loci C Jacquot, J Szymanska, LJ Nemana, LS Steinbach, AE Horvai Skeletal radiology 44, 1695-1699, 2015 | 30 | 2015 |
| Efforts toward elimination of infectious agents in blood products C Jacquot, M Delaney Journal of intensive care medicine 33 (10), 543-550, 2018 | 28 | 2018 |
| Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn A Leonard, L Hittson Boal, P Pary, YD Mo, C Jacquot, NL Luban, ... Transfusion 59 (4), 1183-1189, 2019 | 27 | 2019 |
| Pathogen‐inactivated blood products for pediatric patients: blood safety, patient safety, or both? C Jacquot, M Delaney Transfusion 58 (9), 2095-2101, 2018 | 24 | 2018 |
| International assessment of massive transfusion protocol contents and indications for activation RR Thomasson, MH Yazer, JD Gorham, NM Dunbar, ... Transfusion 59 (5), 1637-1643, 2019 | 22 | 2019 |
| Is posterior reversible encephalopathy syndrome really reversible? Autopsy findings 4.5 years after radiographic resolution. C Jacquot, CM Glastonbury, T Tihan Clinical Neuropathology 34 (1), 26-33, 2015 | 22 | 2015 |
| Synthesis of 11-thialinoleic acid and 14-thialinoleic acid, inhibitors of soybean and human lipoxygenases C Jacquot, CM McGinley, E Plata, TR Holman, WA Van Der Donk Organic & biomolecular chemistry 6 (22), 4242-4252, 2008 | 22 | 2008 |
| Kinetic isotope effects in the oxidation of arachidonic acid by soybean lipoxygenase-1 C Jacquot, S Peng, WA van der Donk Bioorganic & medicinal chemistry letters 18 (22), 5959-5962, 2008 | 17 | 2008 |
| Prolonged ceftriaxone‐induced immune thrombocytopenia due to impaired drug clearance: a case report C Jacquot, M Moayeri, B Kim, S Shugarts, KL Lynch, AD Leavitt Transfusion 53 (11), 2715-2721, 2013 | 14 | 2013 |
| Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee TS Ipe, JS Raval, LP Fernando, A Gokhale, C Jacquot, AD Johnson, ... Journal of clinical apheresis 35 (1), 25-32, 2020 | 13 | 2020 |
| The BEST criteria improve sensitivity for detecting positive cultures in residual blood components cultured in suspected septic transfusion reactions AW Shih, CS Cohn, M Delaney, MJ Fontaine, I Martin, NM Dunbar, ... Transfusion 59 (7), 2292-2300, 2019 | 11 | 2019 |
| New approaches and trials in pediatric transfusion medicine C Jacquot, YD Mo, NLC Luban Hematology/Oncology Clinics 33 (3), 507-520, 2019 | 11 | 2019 |
| Blood donor eligibility criteria for medical conditions: A BEST collaborative study C Jacquot, P Tiberghien, K van den Hurk, A Ziman, B Shaz, TO Apelseth, ... Vox sanguinis 117 (7), 929-936, 2022 | 7 | 2022 |
| Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease A Rankin, D Darbari, A Campbell, J Webb, YD Mo, C Jacquot, M Delaney, ... Transfusion 61 (8), 2255-2264, 2021 | 7 | 2021 |
| Limitations of current practices in detection of bacterially contaminated blood products associated with suspected septic transfusion reactions IW Martin, CS Cohn, M Delaney, MJ Fontaine, AW Shih, NM Dunbar, ... Transfusion 61 (8), 2414-2420, 2021 | 6 | 2021 |
